We are live on ! Find out more
LCM

Leisure Capital Management Portfolio holdings

AUM $320M
1-Year Est. Return 39.11%
This Fund
S&P 500
This Quarter Est. Return
-2.33%
1 Year Est. Return
+39.11%
3 Year Est. Return
+98%
5 Year Est. Return
+122.27%
10 Year Est. Return
+395.27%
AUM
$101M
AUM Growth
-$495K
Cap. Flow
+$2.56M
Cap. Flow %
2.53%
Top 10 Hldgs %
30.9%
Holding
102
New
4
Increased
59
Reduced
17
Closed
6

Sector Composition

Rank Sector Weight
1 Financials 14.37%
2 Healthcare 10.82%
3 Industrials 10.77%
4 Energy 10.44%
5 Technology 8.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNF icon
76
Fidelity National Financial
FNF
$13.9B
$220K 0.22%
8,565
FTI icon
77
TechnipFMC
FTI
$27.2B
$220K 0.22%
+7,142
New +$220K
INTC icon
78
Intel
INTC
$458B
$220K 0.22%
7,229
-2,056
-22% -$66.5K
SEIC icon
79
SEI Investments
SEIC
$12.4B
$211K 0.21%
+4,305
New +$202K
MRK icon
80
Merck
MRK
$315B
$205K 0.2%
3,770
AORT icon
81
Artivion
AORT
$1.35B
$201K 0.2%
17,810
+1,030
+6% +$10.9K
NKTR icon
82
Nektar Therapeutics
NKTR
$2.34B
$196K 0.19%
1,047
+147
+16% +$25.3K
AERI
83
DELISTED
Aerie Pharmaceuticals
AERI
$194K 0.19%
+10,975
New +$201K
NBR icon
84
Nabors Industries
NBR
$1.23B
$190K 0.19%
263
+14
+6% +$10.6K
OSGB
85
DELISTED
OVERSEAS SHIPHOLDING GROUP, INC. COM CL B
OSGB
$163K 0.16%
51,073
+12,583
+33% +$44.7K
NBSE
86
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$162K 0.16%
161
+9
+6% +$9.71K
ARCT icon
87
Arcturus Therapeutics
ARCT
$169M
$148K 0.15%
3,229
+184
+6% +$8.43K
ECYT
88
DELISTED
Endocyte, Inc. Common Stock
ECYT
$145K 0.14%
28,013
+1,648
+6% +$9.88K
RAD
89
DELISTED
Rite Aid Corporation
RAD
$129K 0.13%
775
CYTK icon
90
Cytokinetics
CYTK
$10.2B
$118K 0.12%
17,567
+1,055
+6% +$6.92K
ARWR icon
91
Arrowhead Research
ARWR
$11.9B
$117K 0.12%
16,301
+951
+6% +$6.54K
CDZI icon
92
Cadiz
CDZI
$265M
$112K 0.11%
12,895
+771
+6% +$6.71K
KGC icon
93
Kinross Gold
KGC
$27.5B
$108K 0.11%
46,634
+8,042
+21% +$19.2K
ENZ
94
DELISTED
Enzo Biochem, Inc.
ENZ
$105K 0.1%
34,618
+2,101
+6% +$5.91K
LEU icon
95
Centrus Energy
LEU
$3.64B
$69K 0.07%
16,723
+857
+5% +$4.07K
IAG icon
96
IAMGOLD
IAG
$8.36B
$41K 0.04%
20,540
+1,169
+6% +$2.53K
BAX icon
97
Baxter International
BAX
$14.5B
-7,241
Closed -$269K
SPY icon
98
State Street SPDR S&P 500 ETF Trust
SPY
$806B
-1,073
Closed -$222K
T icon
99
AT&T
T
$162B
-9,596
Closed -$237K
PBY
100
DELISTED
PEP BOYS MANNY MOE& JACK
PBY
-15,599
Closed -$150K

Similar funds

Leisure Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Leisure Capital Management held 102 positions worth $101M, down 0.49% from $102M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Leisure Capital Management's Q2 2015 filing shows 4 new, 59 increased, 17 reduced and 6 closed positions. Its largest new stake was H&R Block: 15,546 shares worth $461K. The largest sale was CIT Group Inc., an estimated $280K.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

  • Leisure Capital Management's largest Q2 2015 buy was H&R Block: 15,546 shares worth $461K.
  • Leisure Capital Management added most to Sabra Healthcare REIT in Q2 2015, an estimated $883K increase.
  • Leisure Capital Management's biggest Q2 2015 reduction was Halozyme, cutting an estimated $91.3K.
  • Leisure Capital Management fully exited CIT Group Inc. in Q2 2015, selling an estimated $280K.
  • Leisure Capital Management's ten largest holdings make up 31% of its $101M portfolio in Q2 2015.
  • Leisure Capital Management opened 4 new positions and closed 6 in Q2 2015.
  • Leisure Capital Management's portfolio value fell 0.49% quarter-over-quarter to $101M.

Based on Leisure Capital Management's 13F filing for Q2 2015, filed 8 Jul 2015.